Novel Biomarker Boosts Diagnostic Accuracy of Nasopharyngeal Cancer Screening

PPV increased to as much as 44.6% with combined-biomarker screening of high-risk patients

Related Keywords

China ,Zhongshan ,Anhui ,Shengxiang ,Heilongjiang ,Xiamen ,Fujian ,Charles Bankhead ,Key Laboratory Of Vaccines ,New England Journal ,State Key Laboratory ,Infectious Diseases ,Southeast Asia ,Medpage Today ,England Journal ,Englj Med ,